| Section | Title | Authors | Address |
|---|
|
| Genes | AGER (advanced glycosylation end product-specific receptor) | Srikrishna G, Hudson B | http://atlasgeneticsoncology.org/Genes/AGERID594ch6p21.html |
| Genes | ALK (anaplastic lymphoma receptor tyrosine kinase) | Allouche M | http://atlasgeneticsoncology.org/Genes/ALKID16.html |
| Genes | AMOT (angiomotin) | Mandrawalia R, Tamuli R | http://atlasgeneticsoncology.org/Genes/AMOTID632chXq23.html |
| Genes | ANG (angiogenin, ribonuclease, RNase A family, 5) | Shimoyama S | http://atlasgeneticsoncology.org/Genes/ANGID635ch14q11.html |
| Genes | ANXA1 (annexin A1) | Rodrigues-Lisoni FC, Henrique T, Tajara EH | http://atlasgeneticsoncology.org/Genes/ANXA1ID653ch9q21.html |
| Genes | ASXL1 (additional sex combs like 1 (Drosophila)) | Mozziconacci MJ, Birnbaum D | http://atlasgeneticsoncology.org/Genes/ASXL1ID44553ch20q11.html |
| Genes | ATF5 (activating transcription factor 5) | Ching AKK, Wong N | http://atlasgeneticsoncology.org/Genes/ATF5ID50361ch19q13.html |
| Genes | ATR (ataxia telangiectasia and Rad3 related) | Gagou ME, Meuth M | http://atlasgeneticsoncology.org/Genes/ATRID728ch3q23.html |
| Genes | AXL (AXL receptor tyrosine kinase) | Migdall J, Graham DK | http://atlasgeneticsoncology.org/Genes/AXLID733ch19q13.html |
| Genes | BABAM2 (brain and reproductive organ-expressed (TNFRSF1A modulator)) | Chui YL, Lee KKH, Chan JYH | http://atlasgeneticsoncology.org/Genes/BREID839ch2p23.html |
| Genes | BACH2 (BTB and CNC homology 1, basic leucine zipper transcription factor 2) | Kjeldsen MK, Dybkaer K, Liu J, Pedersen FS | http://atlasgeneticsoncology.org/Genes/BACH2ID741ch6q15.html |
| Genes | BAK1 (BCL2-antagonist/killer 1) | Dewson G, Kluck R | http://atlasgeneticsoncology.org/Genes/BAK1ID752ch6p21.html |
| Genes | BRCA2 (breast cancer 2, early onset) | Guénard F, Durocher F | http://atlasgeneticsoncology.org/Genes/BRCA2ID164ch13q13.html |
| Genes | CAMTA1 (calmodulin binding transcription activator 1) | Henrich KO | http://atlasgeneticsoncology.org/Genes/CAMTA1ID908ch1p36.html |
| Genes | CCR1 (chemokine (C-C motif) receptor 1) | Gao Q, Fan J | http://atlasgeneticsoncology.org/Genes/CCR1ID44379ch3p21.html |
| Genes | CHD5 (chromodomain helicase DNA binding protein 5) | Brodeur GM, White PS | http://atlasgeneticsoncology.org/Genes/CHD5ID44521ch1p36.html |
| Genes | CITED2 (Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2) | Haase M, Willenberg HS | http://atlasgeneticsoncology.org/Genes/CITED2ID40087ch6q24.html |
| Genes | CKS2 (CDC28 protein kinase regulatory subunit 2) | Zhang Y | http://atlasgeneticsoncology.org/Genes/CKS2ID40093ch9q22.html |
| Genes | CRTC2 (CREB regulated transcription coactivator 2) | Brown KA, Samarageewa N | http://atlasgeneticsoncology.org/Genes/CRTC2ID50581ch1q21.html |
| Genes | CTNND1 (catenin (cadherin-associated protein), delta 1) | Dohn MR, Reynolds AB | http://atlasgeneticsoncology.org/Genes/CTNND1ID40197ch11q11.html |
| Genes | CYLD (cylindromatosis (turban tumor syndrome)) | Courtois G | http://atlasgeneticsoncology.org/Genes/CYLDID40232ch16q12.html |
| Genes | CYP7A1 (cytochrome P450, family 7, subfamily A, polypeptide 1) | Norlin M, Wikvall K | http://atlasgeneticsoncology.org/Genes/CYP7A1ID40254ch8q12.html |
| Genes | DCC (deleted in colorectal carcinoma) | Derks S, van Engeland M | http://atlasgeneticsoncology.org/Genes/DCCID331ch18q21.html |
| Genes | DDX1 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 1) | Hara T, Tanaka K | http://atlasgeneticsoncology.org/Genes/DDX1ID40283ch2p24.html |
| Genes | DEFB1 (defensin, beta 1) | Prado Montes de Oca E | http://atlasgeneticsoncology.org/Genes/DEFB1ID44352ch8p23.html |
| Genes | DIO2 (deiodinase, iodothyronine, type II) | Maia AL, Wajner SM, Leiria LB | http://atlasgeneticsoncology.org/Genes/DIO2ID44390ch14q31.html |
| Genes | DLC1 (deleted in liver cancer 1) | Ko FCF, Ng IOL, Yam JWP | http://atlasgeneticsoncology.org/Genes/DLC1ID40328ch8p22.html |
| Genes | DUSP10 (dual specificity phosphatase 10) | Nonn L | http://atlasgeneticsoncology.org/Genes/DUSP10ID49913ch1q41.html |
| Genes | DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A) | Arbonés ML, de la Luna S | http://atlasgeneticsoncology.org/Genes/DYRK1AID43234ch21q22.html |
| Genes | EGR1 (Early Growth Response 1) | Bandyopadhyay R, Baron V | http://atlasgeneticsoncology.org/Genes/EGR1ID496ch5q31.html |
| Genes | EIF3A (eukaryotic translation initiation factor 3, subunit A) | Yin JY, Dong Z, Zhang JT | http://atlasgeneticsoncology.org/Genes/EIF3AID40425ch10q26.html |
| Genes | EIF4E (eukaryotic translation initiation factor 4E) | Borden KLB, Culjkovic-Kraljacic B, Volpon L | http://atlasgeneticsoncology.org/Genes/EIF4EID40431ch4q23.html |
| Genes | ERG (v-ets erythroblastosis virus E26 oncogene like (avian)) | Menon R, Braun M, Perner S | http://atlasgeneticsoncology.org/Genes/ERGID53ch21q22.html |
| Genes | ETS1 (v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)) | Lindstrot A, Langer B, Wernert N | http://atlasgeneticsoncology.org/Genes/ETS1ID40502ch11q24.html |
| Genes | ETV4 (ets variant 4) | Miyata Y | http://atlasgeneticsoncology.org/Genes/ETV4ID133ch17q21.html |
| Genes | EWSR1 (Ewing sarcoma breakpoint region 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/EWSR1ID85.html |
| Genes | FAM57A (family with sequence similarity 57, member A) | Chen Z, He X | http://atlasgeneticsoncology.org/Genes/FAM57AID40183ch17p13.html |
| Genes | FBLN1 (fibulin 1) | Castagnoli L, Tagliabue E, Pupa SM | http://atlasgeneticsoncology.org/Genes/FBLN1ID44462ch22q13.html |
| Genes | FEN1 (flap structure-specific endonuclease 1) | Finger LD, Shen B | http://atlasgeneticsoncology.org/Genes/FEN1ID40543ch11q12.html |
| Genes | FGF2 (fibroblast growth factor 2 (basic)) | MacFarlane LA, Murphy P | http://atlasgeneticsoncology.org/Genes/FGF2ID511ch4q27.html |
| Genes | FOXA1 (forkhead box A1) | Nakshatri H, Badve S | http://atlasgeneticsoncology.org/Genes/FOXA1ID44403ch14q21.html |
| Genes | FOXE1 (forkhead box E1 (thyroid transcription factor 2)) | Venza I, Visalli M, Teti D, Venza M | http://atlasgeneticsoncology.org/Genes/FOXE1ID47197ch9q22.html |
| Genes | FST (follistatin) | Grusch M | http://atlasgeneticsoncology.org/Genes/FSTID44477ch5q11.html |
| Genes | FUT8 (fucosyltransferase 8 (alpha (1,6) fucosyltransferase)) | Ihara H, Gao CX, Ikeda Y, Taniguchi N | http://atlasgeneticsoncology.org/Genes/FUT8ID40649ch14q23.html |
| Genes | GAB2 (GRB2-associated binding protein 2) | Brummer T | http://atlasgeneticsoncology.org/Genes/GAB2ID40664ch11q14.html |
| Genes | GATA6 (GATA binding protein 6) | Adam RM, Mauney JR | http://atlasgeneticsoncology.org/Genes/GATA6ID40690ch18q11.html |
| Genes | GFI1B (growth factor independent 1B transcription repressor) | Möröy T, Vassen L | http://atlasgeneticsoncology.org/Genes/GFI1BID40707ch9q34.html |
| Genes | GPC5 (glypican 5) | Thway K, Selfe J, Shipley J | http://atlasgeneticsoncology.org/Genes/GPC5ID45705ch13q31.html |
| Genes | GSDMA (gasdermin A) | Saeki N, Sasaki H | http://atlasgeneticsoncology.org/Genes/GSDMAID45650ch17q21.html |
| Genes | GSK3B (glycogen synthase kinase 3 beta) | Thotala DK, Yazlovitskaya EM | http://atlasgeneticsoncology.org/Genes/GSK3BID40761ch3q13.html |
| Genes | HDAC2 (histone deacetylase 2) | Ropero S, Esteller M | http://atlasgeneticsoncology.org/Genes/HDAC2ID40803ch6q22.html |
| Genes | HIPK2 (homeodomain interacting protein kinase 2) | Sombroek D, Hofmann TG | http://atlasgeneticsoncology.org/Genes/HIPK2ID40824ch7q34.html |
| Genes | HLTF (helicase-like transcription factor) | Dimitrova J, Belayew A | http://atlasgeneticsoncology.org/Genes/HLTFID42332ch3q24.html |
| Genes | HUS1 (HUS1 checkpoint homolog (S. pombe)) | Madabushi A, Gunther RC, Lu AL | http://atlasgeneticsoncology.org/Genes/HUS1ID40899ch7p12.html |
| Genes | IGF2BP1 (insulin-like growth factor 2 mRNA binding protein 1) | Trangas T, Ioannidis P | http://atlasgeneticsoncology.org/Genes/IGF2BP1ID40969ch17q21.html |
| Genes | IGSF8 (immunoglobulin superfamily, member 8) | Zhang YH, Richardson MM, Zhang XA | http://atlasgeneticsoncology.org/Genes/IGSF8ID45820ch1q23.html |
| Genes | IL22 (interleukin 22) | Gelebart P, Lai R | http://atlasgeneticsoncology.org/Genes/IL22ID44519ch12q15.html |
| Genes | IL22RA1 (interleukin 22 receptor, alpha 1) | Gelebart P, Lai R | http://atlasgeneticsoncology.org/Genes/IL22RA1ID44568ch1p36.html |
| Genes | IL23A (interleukin 23, alpha subunit p19) | Inoue N | http://atlasgeneticsoncology.org/Genes/IL23AID44517ch12q13.html |
| Genes | ING4 (inhibitor of growth family, member 4) | Greco A, Miranda C | http://atlasgeneticsoncology.org/Genes/ING4ID40978ch12p13.html |
| Genes | KIAA1524 | Khanna A, Okkeri J, Westermarck J | http://atlasgeneticsoncology.org/Genes/KIAA1524ID44402ch3q13.html |
| Genes | LATS2 (LATS, large tumor suppressor, homolog 2 (Drosophila)) | Glavač D, Stražišar M | http://atlasgeneticsoncology.org/Genes/LATS2ID41128ch13q12.html |
| Genes | LGALS3 (lectin, galactoside-binding, soluble, 3) | Nangia-Makker P, Balan V, Raz A | http://atlasgeneticsoncology.org/Genes/LGALS3ID44396ch14q22.html |
| Genes | LRIG1 (leucine-rich repeats and immunoglobulin-like domains 1) | Guo D, Wang B | http://atlasgeneticsoncology.org/Genes/LRIG1ID41198ch3p14.html |
| Genes | LRP5 (low density lipoprotein receptor-related protein 5) | Zhong ZA, Williams BO | http://atlasgeneticsoncology.org/Genes/LRP5ID44282ch11q13.html |
| Genes | MACROD1 (MACRO domain containing 1) | Han W, Ma X, Duan Y, Wu Z | http://atlasgeneticsoncology.org/Genes/MACROD1ID50947ch11q13.html |
| Genes | MAL (mal, T-cell differentiation protein) | Beder LB, Yamanaka N | http://atlasgeneticsoncology.org/Genes/MALID46222ch2q11.html |
| Genes | MAPK1 (mitogen-activated protein kinase 1) | Tuncay S, Banerjee S | http://atlasgeneticsoncology.org/Genes/MAPK1ID41288ch22q11.html |
| Genes | MAPK12 (mitogen-activated protein kinase 12) | Cerezo-Guisado MI, Cuenda A | http://atlasgeneticsoncology.org/Genes/MAPK12ID41290ch22q13.html |
| Genes | MAPK14 (mitogen-activated protein kinase 14) | Porras A, Guerrero C | http://atlasgeneticsoncology.org/Genes/MAPK14ID41292ch6p21.html |
| Genes | MAPK3 (mitogen-activated protein kinase 3) | Tuncay S, Banerjee S | http://atlasgeneticsoncology.org/Genes/MAPK3ID425ch16p11.html |
| Genes | MAPK7 (mitogen-activated protein kinase 7) | Iñesta-Vaquera FdA, Cuenda A | http://atlasgeneticsoncology.org/Genes/MAPK7ID41294ch17p11.html |
| Genes | MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2) | Felix R, Alves V, Vettore A, Colleoni G | http://atlasgeneticsoncology.org/Genes/MAPKAPK2ID41295ch1q32.html |
| Genes | MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor)) | Bach JP, Bacher M, Dodel R | http://atlasgeneticsoncology.org/Genes/MIFID41365ch22q11.html |
| Genes | MIXL1 (Mix1 homeobox-like 1 (Xenopus laevis)) | Raymond A, Nagarajan L | http://atlasgeneticsoncology.org/Genes/MIXL1ID47624ch1q42.html |
| Genes | MMP14 (matrix metallopeptidase 14 (membrane-inserted)) | Kuscu C, Evensen N, Cao J | http://atlasgeneticsoncology.org/Genes/MMP14ID41391ch14q11.html |
| Genes | MRC1 (mannose receptor, C type 1) | Rasi S, Bruscaggin A, Gaidano G | http://atlasgeneticsoncology.org/Genes/MRC1ID44561ch10p12.html |
| Genes | MTA3 (metastasis associated 1 family, member 3 ) | Brüning A, Mylonas I | http://atlasgeneticsoncology.org/Genes/MTA3ID41445ch2p21.html |
| Genes | MUC13 (mucin 13, cell surface associated) | Maher D, Gupta B, Ebeling M, Nagata S, Jaggi M, Chauhan SC | http://atlasgeneticsoncology.org/Genes/MUC13ID41454ch3q21.html |
| Genes | NEU3 (sialidase 3 (membrane sialidase)) | Yamaguchi K, Miyagi T | http://atlasgeneticsoncology.org/Genes/NEU3ID44505ch11q13.html |
| Genes | NKX2-1 (NK2 homeobox 1) | Wilbertz T, Maier S, Perner S | http://atlasgeneticsoncology.org/Genes/NKX2-1ID44015ch14q13.html |
| Genes | NMT1 (N-myristoyltransferase 1) | Selvakumar P, Kumar S, Dimmock JR, Sharma RK | http://atlasgeneticsoncology.org/Genes/NMT1ID43604ch17q21.html |
| Genes | NPY1R (neuropeptide Y receptor Y1) | Ruscica M, Dozio E, Passafaro L, Magni P | http://atlasgeneticsoncology.org/Genes/NPY1RID44260ch4q32.html |
| Genes | NUDT6 (nudix (nucleoside diphosphate linked moiety X)-type motif 6) | MacFarlane LA, Murphy P | http://atlasgeneticsoncology.org/Genes/NUDT6ID41593ch4q28.html |
| Genes | OLFM4 (olfactomedin 4) | Liu W, Rodgers GP | http://atlasgeneticsoncology.org/Genes/OLFM4ID49730ch13q14.html |
| Genes | OTX2 (orthodenticle homeobox 2) | Wortham M | http://atlasgeneticsoncology.org/Genes/OTX2ID46429ch14q22.html |
| Genes | PAEP (progestagen-associated endometrial protein) | Koistinen H, Seppälä M | http://atlasgeneticsoncology.org/Genes/PAEPID46067ch9q34.html |
| Genes | PARVB (parvin, beta) | Johnstone CN | http://atlasgeneticsoncology.org/Genes/PARVBID46486ch22q13.html |
| Genes | PDE11A (phosphodiesterase 11A) | Libé R, Bertherat J | http://atlasgeneticsoncology.org/Genes/PDE11AID44448ch2q31.html |
| Genes | PDX1 (pancreatic and duodenal homeobox 1) | Zhou G, Brunicardi FC | http://atlasgeneticsoncology.org/Genes/PDX1ID43921ch13q12.html |
| Genes | PEG3 (paternally expressed 3) | Yu Y, Feng W, Lu Z, Bast RC Jr | http://atlasgeneticsoncology.org/Genes/PEG3ID41690ch19q13.html |
| Genes | PIAS3 (protein inhibitor of activated STAT, 3) | Spoden G, Zwerschke W | http://atlasgeneticsoncology.org/Genes/PIAS3ID41709ch1q21.html |
| Genes | PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid)) | Cormier RT | http://atlasgeneticsoncology.org/Genes/PLA2G2AID41730ch1p36.html |
| Genes | PLD1 (phospholipase D1, phosphatidylcholine-specific) | Lee CS, Ryu SH | http://atlasgeneticsoncology.org/Genes/PLD1ID43716ch3q26.html |
| Genes | PSEN2 (presenilin 2 (Alzheimer disease 4)) | Newman M | http://atlasgeneticsoncology.org/Genes/PSEN2ID41883ch1q42.html |
| Genes | PTPN7 (protein tyrosine phosphatase, non-receptor type 7) | Fridberg M, Tassidis H, Gjörloff Wingren A | http://atlasgeneticsoncology.org/Genes/PTPN7ID41921ch1q32.html |
| Genes | RAD51D (RAD51-like 3 (S. cerevisiae)) | Taylor MK, Bedenbaugh MK, Brown SM, Yard BD, Pittman DL | http://atlasgeneticsoncology.org/Genes/RAD51L3ID347ch17q12.html |
| Genes | RAD9A (RAD9 homolog A (S. pombe)) | Chan V | http://atlasgeneticsoncology.org/Genes/RAD9AID42031ch11q13.html |
| Genes | RAP1GAP (RAP1 GTPase activating protein) | Chen Z, Shao X | http://atlasgeneticsoncology.org/Genes/RAP1GAPID42043ch1p36.html |
| Genes | RAPGEF1 (Rap guanine nucleotide exchange factor (GEF) 1) | Mitra A, Radha V | http://atlasgeneticsoncology.org/Genes/RAPGEF1ID42045ch9q34.html |
| Genes | RASSF6 (Ras association (RalGDS/AF-6) domain family member 6) | Hesson LB, Latif F | http://atlasgeneticsoncology.org/Genes/RASSF6ID43462ch4q13.html |
| Genes | REPS2 (RALBP1 associated Eps domain containing 2) | Corallino S, Castagnoli L | http://atlasgeneticsoncology.org/Genes/REPS2ID44120chXp22.html |
| Genes | REST (RE1-silencing transcription factor) | Faronato M, Coulson JM | http://atlasgeneticsoncology.org/Genes/RESTID44266ch4q12.html |
| Genes | RGS2 (regulator of G-protein signaling 2, 24kDa) | Nguyen CH | http://atlasgeneticsoncology.org/Genes/RGS2ID42102ch1q31.html |
| Genes | RIOX2 (ribosomal oxygenase 2) | Tsuneoka M, Okamoto K, Tanaka Y | http://atlasgeneticsoncology.org/Genes/MINAID44409ch3q11.html |
| Genes | ROR2 (receptor tyrosine kinase-like orphan receptor 2) | Wright TM, Rathmell WK | http://atlasgeneticsoncology.org/Genes/ROR2ID43476ch9q22.html |
| Genes | RPA2 (replication protein A2, 32kDa) | Murphy AKZ, Borowiec JA | http://atlasgeneticsoncology.org/Genes/RPA2ID42146ch1p35.html |
| Genes | RPL10 (ribosomal protein L10) | Goel M, Tamuli R | http://atlasgeneticsoncology.org/Genes/RPL10ID42148chXq28.html |
| Genes | RPL26 (ribosomal protein L26) | Boggs K, Kastan M | http://atlasgeneticsoncology.org/Genes/RPL26ID47470ch17p13.html |
| Genes | S100A7 (S100 calcium binding protein A7) | Murray JI, Boulanger MJ | http://atlasgeneticsoncology.org/Genes/S100A7ID42194ch1q21.html |
| Genes | SCAF1 (SR-related CTD-associated factor 1) | Kontos C, Scorilas A | http://atlasgeneticsoncology.org/Genes/SCAF1ID46074ch19q13.html |
| Genes | SELENOF (15 kDa selenoprotein) | Jablonska E, Gromadzinska J, Reszka E, Wasowicz W | http://atlasgeneticsoncology.org/Genes/SEP15ID42260ch1p22.html |
| Genes | SHBG (sex hormone-binding globulin) | Fortunati N, Catalano MG | http://atlasgeneticsoncology.org/Genes/SHBGID42286ch17p13.html |
| Genes | SIPA1 (signal-induced proliferation-associated 1) | Hattori M | http://atlasgeneticsoncology.org/Genes/SIPA1ID46282ch11q13.html |
| Genes | SIRT1 (sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)) | Tseng RC, Wan YC | http://atlasgeneticsoncology.org/Genes/SIRT1ID44006ch10q21.html |
| Genes | SLC16A1 (solute carrier family 16, member 1 (monocarboxylic acid transporter 1)) | Pinheiro C, Baltazar F | http://atlasgeneticsoncology.org/Genes/SLC16A1ID44046ch1p13.html |
| Genes | SLC16A3 (solute carrier family 16, member 3 (monocarboxylic acid transporter 4)) | Pinheiro C, Baltazar F | http://atlasgeneticsoncology.org/Genes/SLC16A3ID44573ch17q25.html |
| Genes | SLC39A6 (solute carrier family 39 (zinc transporter), member 6) | Hamada S, Satoh K, Shimosegawa T | http://atlasgeneticsoncology.org/Genes/SLC39A6ID44189ch18q12.html |
| Genes | SLC4A1 (solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)) | Fu GH | http://atlasgeneticsoncology.org/Genes/SLC4A1ID42325ch17q21.html |
| Genes | SLC9A3R1 (solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1) | McDonough WS, Berens ME | http://atlasgeneticsoncology.org/Genes/SLC9A3R1ID46023ch17q25.html |
| Genes | SMYD3 (SET and MYND domain containing 3) | Luo XG, Guo S, Zhang TC | http://atlasgeneticsoncology.org/Genes/SMYD3ID46100ch1q44.html |
| Genes | SNAI1 (snail homolog 1 (Drosophila)) | Schwock J, Geddie WR | http://atlasgeneticsoncology.org/Genes/SNAI1ID452ch20q13.html |
| Genes | SOX10 (SRY (sex determining region Y)-box 10) | Wegner M | http://atlasgeneticsoncology.org/Genes/SOX10ID43768ch22q13.html |
| Genes | SOX11 (SRY (sex determining region Y)-box 11) | Wang X, Sander B | http://atlasgeneticsoncology.org/Genes/SOX11ID42357ch2p25.html |
| Genes | SPAM1 (sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)) | Sade A, Banerjee S | http://atlasgeneticsoncology.org/Genes/SPAM1ID42361ch7q31.html |
| Genes | STEAP2 (six transmembrane epithelial antigen of the prostate 2) | Maia C, Socorro S, Santos C | http://atlasgeneticsoncology.org/Genes/STEAP2ID42435ch7q21.html |
| Genes | STOML2 (stomatin (EPB72)-like 2) | Cao W, Zhang L, Ding F, Cui Z, Liu Z | http://atlasgeneticsoncology.org/Genes/STOML2ID44346ch9p13.html |
| Genes | TAGLN (transgelin) | Assinder S | http://atlasgeneticsoncology.org/Genes/TAGLNID46168ch11q23.html |
| Genes | THRSP (thyroid hormone responsive) | Kuemmerle NB, Kinlaw WB | http://atlasgeneticsoncology.org/Genes/THRSPID42555ch11q14.html |
| Genes | THY1 (Thy-1 cell surface antigen) | Bradley JE, Hagood JS | http://atlasgeneticsoncology.org/Genes/THY1ID45672ch11q23.html |
| Genes | TMPRSS2 (transmembrane protease, serine 2) | Park Y | http://atlasgeneticsoncology.org/Genes/TMPRSS2ID42592ch21q22.html |
| Genes | TMSB10 (thymosin beta 10) | Qiu X | http://atlasgeneticsoncology.org/Genes/TMSB10ID42595ch2p11.html |
| Genes | TNFSF18 (tumor necrosis factor (ligand) superfamily, member 18) | Placke T, Kopp HG, Schmiedel BJ, Salih HR | http://atlasgeneticsoncology.org/Genes/TNFSF18ID42639ch1q25.html |
| Genes | TPD52 (tumor protein D52) | Della-Franca A, Byrne J | http://atlasgeneticsoncology.org/Genes/TPD52ID42676ch8q21.html |
| Genes | TRAP1 (TNF receptor-associated protein 1) | Bellizzi D, Passarino G | http://atlasgeneticsoncology.org/Genes/TRAP1ID42692ch16p13.html |
| Genes | TRIO (triple functional domain (PTPRF interacting)) | Schmidt S, Debant A | http://atlasgeneticsoncology.org/Genes/TRIOID43542ch5p15.html |
| Genes | TRPV1 (transient receptor potential cation channel, subfamily V, member 1) | Nabissi M, Santoni G | http://atlasgeneticsoncology.org/Genes/TRPV1ID50368ch17p13.html |
| Genes | TYMP (thymidine phosphorylase) | Bijnsdorp IV, Peters GJ | http://atlasgeneticsoncology.org/Genes/TYMPID40397ch22q13.html |
| Genes | TYRO3 (TYRO3 protein tyrosine kinase) | Jacobsen KM, Linger RMA, Graham DK | http://atlasgeneticsoncology.org/Genes/TYRO3ID42739ch15q15.html |
| Genes | USF1 (upstream transcription factor 1) | Verhoeven AJM | http://atlasgeneticsoncology.org/Genes/USF1ID45856ch1q23.html |
| Genes | USP15 (ubiquitin specific peptidase 15) | Faronato M, Urbé S, Coulson JM | http://atlasgeneticsoncology.org/Genes/USP15ID44585ch12q14.html |
| Genes | VAV3 (vav 3 guanine nucleotide exchange factor) | Lyons L, Burnstein KL | http://atlasgeneticsoncology.org/Genes/VAV3ID42782ch1p13.html |
| Genes | VCAN (versican) | Hernández D, Docampo MJ, Bassols A | http://atlasgeneticsoncology.org/Genes/VCANID40173ch5q14.html |
| Genes | WNK2 (WNK lysine deficient protein kinase 2) | Jordan P | http://atlasgeneticsoncology.org/Genes/WNK2ID41867ch9q22.html |
| Genes | WRAP53 (WD repeat containing, antisense to TP53) | Farnebo M | http://atlasgeneticsoncology.org/Genes/WRAP53ID50705ch17p13.html |
| Genes | XRCC6 (X-ray repair complementing defective repair in Chinese hamster cells 6) | Pucci S, Zonetti MJ | http://atlasgeneticsoncology.org/Genes/XRCC6ID246ch22q13.html |
| Genes | YAP1 (Yes-associated protein 1, 65kDa) | Di Agostino S, Strano S, Blandino G | http://atlasgeneticsoncology.org/Genes/YAP1ID42855ch11q22.html |
| Genes | YBX1 (Y box binding protein 1) | Evdokimova V, Sorokin A | http://atlasgeneticsoncology.org/Genes/YBX1ID46554ch1p34.html |
| Genes | ZBTB33 (zinc finger and BTB domain containing 33) | Dohn MR, Reynolds AB | http://atlasgeneticsoncology.org/Genes/ZBTB33ID43785chXq24.html |
| Leukemias | 8p11 myeloproliferative syndrome (FGFR1) | Aranaz P, Vizmanos JL | http://atlasgeneticsoncology.org/Anomalies/8p11inMPDID1091.html |
| Leukemias | ALK -positive diffuse large B-cell lymphoma | Cuneo A, Rigolin GM, Ciccone M | http://atlasgeneticsoncology.org/Anomalies/ALKDLBCLID1552.html |
| Leukemias | Anaplastic B-cell lymphoma | Cuneo A, Rigolin GM, Cavazzini F | http://atlasgeneticsoncology.org/Anomalies/AnaplastBLymphID2093.html |
| Leukemias | Centroblastic lymphoma | Cuneo A, Rigolin GM, Cavazzini F | http://atlasgeneticsoncology.org/Anomalies/CentroLymphoID2091.html |
| Leukemias | Hodgkin lymphoma | Küppers R | http://atlasgeneticsoncology.org/Anomalies/HodgkinID2068.html |
| Leukemias | Immunoblastic lymphoma | Cuneo A, Rigolin GM, Cavazzini F | http://atlasgeneticsoncology.org/Anomalies/ImmunoLymphoID2092.html |
| Leukemias | MLL amplification in leukemia | Mohamed A | http://atlasgeneticsoncology.org/Anomalies/MLLampliID1547.html |
| Leukemias | der(6)t(1;6)(q21-23;p21) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/der6t0106q21p21ID1546.html |
| Leukemias | dic(3;9)(p14;p13) PAX5/FOXP1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0309p14p13ID1553.html |
| Leukemias | dic(7;9)(p11-12;p12-13) PAX5/LOC392027 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0709p11p12ID1554.html |
| Leukemias | dic(9;12)(p13;p12) PAX5/SLCO1B3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0912p13p12ID1555.html |
| Leukemias | dic(9;18)(p13;q11) PAX5/ZNF521 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0918p13q11ID1556.html |
| Leukemias | i(5)(p10) in acute myeloid leukemia | Douet-Guilbert N, Herry A, Basinko A, Le Bris MJ, Guéganic N, Bovo C, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/i5pID1376.html |
| Leukemias | ins(9;4)(q33;q12q25) CDK5RAP2/PDGFRA | Huret JL | http://atlasgeneticsoncology.org/Anomalies/ins0904q33q12q25ID1450.html |
| Leukemias | t(1;11)(p32;q23) KMT2A/EPS15 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0111p32q23ID1046.html |
| Leukemias | t(1;2)(p36;p21) THADA/PRDM16 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0102p36p21ID1542.html |
| Leukemias | t(2;14)(p13-16;q32) IGH/BCL11A | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0214p13q32ID1231.html |
| Leukemias | t(2;18)(q11;q21) AFF3/BCL2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0218q11q21ID2158.html |
| Leukemias | t(2;21)(q11;q22) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0221q11q22ID1551.html |
| Leukemias | t(3;12)(q27;p13) GAPDH/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0312q27p13ID1337.html |
| Leukemias | t(3;3)(q25;q27) MBNL1/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0303q25q27ID2127.html |
| Leukemias | t(3;5)(p21;q32) RBM6/CSF1R | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0305p21q32ID2139.html |
| Leukemias | t(6;22)(p21;q11) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Bone: Giant cell tumour with t(11;22)(q24;q12) EWSR1/FLI1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Eye tumors: an overview | Williams BK Jr, Schefler AC, Murray TG | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Head and Neck: Odontogenic tumor: Ameloblastoma | Angadi PV | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Head and Neck: Salivary gland tumors: Mucoepidermoid carcinoma with t(6;22)(p21;q12) EWSR1/POU5F1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Head and Neck: Salivary gland tumors: an overview | Rousseau A, Badoual C | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Liver: Nested stromal epithelial tumor | Yeh YA | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Lung: Pleuropulmonary blastoma | Yeh YA, Edelman MC | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Pancreas: Solid pseudopapillary tumour of the pancreas with t(11;22)(q24;q12) EWSR1/FLI1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Skin: Hidradenoma with t(6;22)(p21;q12) EWSR1/POU5F1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Soft Tissues: Alveolar rhabdomyosarcoma with t(1;13)(p36;q14) PAX7/FOXO1 | Barr FG | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Soft Tissues: Alveolar rhabdomyosarcoma with t(2;13)(q35;q14) PAX3/FOXO1 | Barr FG | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Soft Tissues: Alveolar rhabdomyosarcoma with t(2;2)(p23;q35) PAX3/NCOA1 | Barr FG | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Soft Tissues: Myoepithelial carcinoma with t(19;22)(q13;q12) EWSR1/ZNF444 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Soft Tissues: Rhabdomyosarcomas with t(11;22)(q24;q12) EWSR1/FLI1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Solid Tumors | Soft Tissues: Undifferentiated sarcoma with t(6;22)(p21;q12) EWSR1/POU5F1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0622p21q11ID1563.html |
| Deep Insights | Glutathione S-Transferase pi (GSTP1) | Meiers I | http://atlasgeneticsoncology.org/Deep/GSTP1inCancerID20084.html |
| Deep Insights | Inhibitors of the heat shock protein 90: from cancer clinical trials to neurodegenerative diseases | Peyrat JF, Messaoudi S, Brion JD, Alami M | http://atlasgeneticsoncology.org/Deep/HSP90inCancerTreatmentID20086.html |
| Deep Insights | LDI-PCR in Cancer Translocation Mapping | Schneider B, Drexler HG, MacLeod RAF | http://atlasgeneticsoncology.org/Deep/LDI-PCRinCancerID20087.html |
| Deep Insights | MTA1 of the MTA (metastasis-associated) gene family and its encoded proteins: molecular and regulatory functions and role in human cancer progression | Toh Y, Nicolson GL | http://atlasgeneticsoncology.org/Deep/MTAinCancerID20088.html |
| Deep Insights | Natural nanoparticules against cancer: mature dendritic cell-derived exosomes | Viaud S, Desbois M, Ploix S, Zitvogel L, Chaput N | http://atlasgeneticsoncology.org/Deep/DexandCancerID20078.html |
| Deep Insights | Role of HB-EGF in cancer | Adam RM | http://atlasgeneticsoncology.org/Deep/HB-EGFinCancerID20090.html |
| Deep Insights | Role of p38α in apoptosis: implication in cancer development and therapy | Porras A, Guerrero C | http://atlasgeneticsoncology.org/Deep/MAPK14-p38ainCancerID20089.html |
| Deep Insights | TMPRSS2:ETS gene fusions in prostate cancer | Williams JL, Yoshimoto M, Boag AH, Squire JA, Park PC | http://atlasgeneticsoncology.org/Deep/TMPRSS2ERGinCancerID20091.html |
| Deep Insights | The roles of SRA1 gene in breast cancer | Yan Y, Cooper C, Leygue E | http://atlasgeneticsoncology.org/Deep/SRA1inCancerID20085.html |
| Deep Insights | Ubiquitin, ubiquitination and the ubiquitin-proteasome system in cancer | Voutsadakis IA | http://atlasgeneticsoncology.org/Deep/UbiquitininCancerID20083.html |
